ACADIAN ASSET MANAGEMENT LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 118 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2017. The put-call ratio across all filers is 1.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$2,000
-50.0%
166
-52.6%
0.00%
Q4 2016$4,0000.0%3500.0%0.00%
Q3 2016$4,0000.0%3500.0%0.00%
Q2 2016$4,000
-33.3%
3500.0%0.00%
Q1 2016$6,000
-40.0%
3500.0%0.00%
Q4 2015$10,000
+11.1%
350
+5.4%
0.00%
Q3 2015$9,000
-98.8%
332
-98.5%
0.00%
-100.0%
Q2 2015$774,000
+6936.4%
21,561
+8098.1%
0.00%
Q1 2014$11,000
-98.4%
263
-98.5%
0.00%
-100.0%
Q4 2013$670,000
+106.8%
17,345
+87.1%
0.00%
+100.0%
Q3 2013$324,0009,2710.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2017
NameSharesValueWeighting ↓
Orbimed Advisors 6,171,440$54,802,0000.52%
Regal Investment Advisors LLC 161,600$1,435,0000.34%
Folger Hill Asset Management LP 396,315$3,519,0000.30%
SCHNEIDER CAPITAL MANAGEMENT CORP 181,900$1,615,0000.29%
Mirae Asset Global Investments Co., Ltd. 1,033,683$9,179,0000.17%
JW Asset Management, LLC 29,409$72,0000.05%
TCI Wealth Advisors, Inc. 9,516$85,0000.04%
GAM Holding AG 83,940$745,0000.03%
Freedom Investment Management, Inc. 63,032$560,0000.03%
Sterling Investment Advisors, Ltd. 5,000$44,0000.03%
View complete list of INSYS THERAPEUTICS INC NEW shareholders